Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management

References

• WHO. Pathology and genetics of tumours of soft tissue and bone. Fletcher CD, Unni KK, Mertens F (Eds). IARC Press, Lyons, (2002).
   Google Scholar
• Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J. Clin. Oncol.20(3), 791–796 (2002).
   PubMed Web of Science ®Google Scholar
• Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann. Surg.228(3), 355–365 (1998).
   PubMed Web of Science ®Google Scholar
• Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am. J. Surg. Pathol.21(3), 271–281 (1997).
   PubMed Web of Science ®Google Scholar
• Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J. Clin. Oncol.19(12), 3045–3050 (2001).
   PubMed Web of Science ®Google Scholar
• Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet369(9574), 1731–1741 (2007).
   PubMed Web of Science ®Google Scholar
• Lal DR, Su WT, Wolden SL et al. Results of multimodal treatment for desmoplastic small round cell tumors. J. Pediatr. Surg.40(1), 251–255 (2005).
   PubMed Web of Science ®Google Scholar
• Fritz B, Schubert F, Wrobel G et al. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res.62(11), 2993–2998 (2002).
   PubMed Web of Science ®Google Scholar
• Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet. Cytogenet.155(1), 1–24 (2004).
   PubMedGoogle Scholar
• Toledo F, Wahl GM. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer6(12), 909–923 (2006).
   PubMed Web of Science ®Google Scholar
• Pilotti S, Della Torre G, Lavarino C et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J. Pathol.181(1), 14–24 (1997).
   PubMed Web of Science ®Google Scholar
• Forus A, Bjerkehagen B, Sirvent N et al. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Cancer Genet. Cytogenet.131(1), 13–18 (2001).
   PubMedGoogle Scholar
• Mariani O, Brennetot C, Coindre JM et al.JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell11(4), 361–374 (2007).
   PubMed Web of Science ®Google Scholar
• Antonescu CR, Elahi A, Healey JH et al. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements. Clin. Cancer Res.6(7), 2788–2793 (2000).
   PubMed Web of Science ®Google Scholar
• Fiore M, Grosso F, Lo Vullo S et al. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution. Cancer109(12), 2522–2531 (2007).
   PubMed Web of Science ®Google Scholar
• Schwab JH, Boland P, Guo T et al. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread. Ann. Surg. Oncol.14(4), 1507–1514 (2007).
   PubMed Web of Science ®Google Scholar
• Pitson G, Robinson P, Wilke D et al. Radiation response: an additional unique signature of myxoid liposarcoma. Int. J. Radiat. Oncol. Biol. Phys.60(2), 522–526 (2004).
   PubMed Web of Science ®Google Scholar
• Guadagnolo BA, Zagars GK, Ballo MT et al. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.70(3), 760–765 (2008).
   PubMed Web of Science ®Google Scholar
• Perez-Losada J, Pintado B, Gutierrez-Adan A et al. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene19(20), 2413–2422 (2000).
   PubMed Web of Science ®Google Scholar
• Perez-Losada J, Sanchez-Martin M, Rodriguez-Garcia MA et al. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene19(52), 6015–6022 (2000).
   PubMed Web of Science ®Google Scholar
• Perez-Mancera PA, Bermejo-Rodriguez C, Sanchez-Martin M et al. FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARg and C/EBPa and activating eIF4E. PLoS ONE3(7), e2569 (2008).
   Google Scholar
• Perez-Mancera PA, Perez-Losada J, Sanchez-Martin M et al. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice. Oncogene21(11), 1679–1684 (2002).
   PubMed Web of Science ®Google Scholar
• Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell11(4), 375–388 (2007).
   PubMed Web of Science ®Google Scholar
• Gerald WL, Haber DA. The EWS–WT1 gene fusion in desmoplastic small round cell tumor. Semin. Cancer Biol.15(3), 197–205 (2005).
   PubMed Web of Science ®Google Scholar
• Tirode F, Laud-Duval K, Prieur A et al. Mesenchymal stem cell features of Ewing tumors. Cancer Cell11(5), 421–429 (2007).
   PubMed Web of Science ®Google Scholar
• Keller C, Arenkiel BR, Coffin CM et al. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev.18(21), 2614–2626 (2004).
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Leung DH, Hoos A et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann. Surg.235(3), 424–434 (2002).
   PubMed Web of Science ®Google Scholar
• Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop. Relat. Res.(153), 106–120 (1980).
   Google Scholar
• Canter RJ, Qin LX, Ferrone CR et al. Why do patients with low-grade soft tissue sarcoma die? Ann. Surg. Oncol.15(12), 3550–3560 (2008).
   PubMed Web of Science ®Google Scholar
• Gronchi A, Casali PG, Fiore M et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer100(11), 2448–2455 (2004).
   PubMed Web of Science ®Google Scholar
• Gronchi A, Casali PG, Mariani L et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J. Clin. Oncol.23(1), 96–104 (2005).
   PubMed Web of Science ®Google Scholar
• Stoeckle E, Coindre JM, Bonvalot S et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer92(2), 359–368 (2001).
   PubMed Web of Science ®Google Scholar
• Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer97(10), 2530–2543 (2003).
   PubMed Web of Science ®Google Scholar
• Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J. Surg. Oncol.98(8), 607–610 (2008).
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Rivoire M, Castaing M et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J. Clin. Oncol.27(1), 31–37 (2009).
   PubMed Web of Science ®Google Scholar
• Gronchi A, Lo Vullo S, Fiore M et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J. Clin. Oncol.27(1), 24–30 (2009).
   PubMed Web of Science ®Google Scholar
• Lahat G, Anaya DA, Wang X et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann. Surg. Oncol.15(6), 1585–1593 (2008).
   PubMed Web of Science ®Google Scholar
• Pisters PW. Resection of some, but not all, clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas. J. Clin. Oncol.27(1), 6–8 (2009).
   PubMed Web of Science ®Google Scholar
• Gerrand CH, Wunder JS, Kandel RA et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J. Bone Joint Surg. Br.83(8), 1149–1155 (2001).
   PubMedGoogle Scholar
• Gronchi A, Miceli R, Fiore M et al. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure. Ann. Surg. Oncol.14(5), 1583–1590 (2007).
   PubMed Web of Science ®Google Scholar
• Mussi C, Collini P, Miceli R et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer113(7), 1657–1665 (2008).
   PubMed Web of Science ®Google Scholar
• Yeh JJ, Singer S, Brennan MF, Jaques DP. Effectiveness of palliative procedures for intra-abdominal sarcomas. Ann. Surg. Oncol.12(12), 1084–1089 (2005).
   PubMed Web of Science ®Google Scholar
• Park JO, Qin LX, Prete F, Brennan MF, Singer S. Growth rate predicts outcome in locally recurrent retroperitoneal sarcoma. Proceedings of the 13th Annual Meeting of the Connective Tissue Oncology Society, Seattle, WA, USA 31 October–3 November (2007) (Abstract 382).
   Google Scholar
• Adjuvant-chemotherapy: adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. sarcoma meta-analysis collaboration. Lancet350(9092), 1647–1654 (1997).
   PubMed Web of Science ®Google Scholar
• Pervaiz N, Colterjohn N, Farrokhyar F et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer113(3), 573–581 (2008).
   PubMed Web of Science ®Google Scholar
• Grier HE, Krailo MD, Tarbell NJ et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N. Engl. J. Med.348(8), 694–701 (2003).
   PubMed Web of Science ®Google Scholar
• Karavasilis V, Seddon BM, Ashley S et al. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients. Cancer112(7), 1585–1591 (2008).
   PubMed Web of Science ®Google Scholar
• Grosso F, Jones RL, Demetri GD et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol.8(7), 595–602 (2007).
   PubMed Web of Science ®Google Scholar
• Le Cesne A, Blay JY, Judson I et al. Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. J. Clin. Oncol.23(3), 576–584 (2005).
   PubMed Web of Science ®Google Scholar
• George S, Merriam P, Maki RG et al. Multicenter Phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J. Clin. Oncol.27(19), 3154–3160 (2009).
   PubMed Web of Science ®Google Scholar
• Maki RG, D’Adamo DR, Keohan ML et al. Phase II study of Sorafenib in patients with metastatic or recurrent sarcomas. J. Clin. Oncol.27(19), 3133–3140 (2009).
   PubMed Web of Science ®Google Scholar
• Hensley ML, Maki R, Venkatraman E et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a Phase II trial. J. Clin. Oncol.20(12), 2824–2831 (2002).
   PubMed Web of Science ®Google Scholar
• Bleyer A, Barr R, Hayes-Lattin B et al. The distinctive biology of cancer in adolescents and young adults. Nat. Rev. Cancer8(4), 288–298 (2008).
   PubMed Web of Science ®Google Scholar
• Khamly KK, Thursfield VJ, Desai J et al. Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood. Int. J. Cancer125(2), 426–431 (2009).
   PubMed Web of Science ®Google Scholar
• Yuen JS, Macaulay VM. Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Expert Opin. Ther. Targets12(5), 589–603 (2008).
   PubMed Web of Science ®Google Scholar
• Stuart-Buttle CE, Smart CJ, Pritchard S, Martin D, Welch IM. Desmoplastic small round cell tumour: a review of literature and treatment options. Surg. Oncol.17(2), 107–112 (2008).
   PubMed Web of Science ®Google Scholar
• Raney RB, Maurer HM, Anderson JR et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma5(1), 9–15 (2001).
   PubMedGoogle Scholar
• Sindelar WF, Kinsella TJ, Chen PW et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch. Surg.128(4), 402–410 (1993).
   PubMedGoogle Scholar
• Borden EC, Baker LH, Bell RS et al. Soft tissue sarcomas of adults: state of the translational science. Clin. Cancer Res.9(6), 1941–1956 (2003).
   PubMed Web of Science ®Google Scholar
• Pisters PW. Retroperitoneal sarcomas – an SOS to colleagues in Europe. Ann. Surg. Oncol.14(6), 1787–1789 (2007).
   PubMed Web of Science ®Google Scholar
• Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer106(7), 1610–1616 (2006).
   PubMed Web of Science ®Google Scholar
• Catton CN, O’Sullivan B, Kotwall C et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int. J. Radiat. Oncol. Biol. Phys.29(5), 1005–1010 (1994).
   PubMed Web of Science ®Google Scholar
• Ballo MT, Zagars GK, Pollock RE et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int. J. Radiat. Oncol. Biol. Phys.67(1), 158–163 (2007).
   PubMed Web of Science ®Google Scholar
• Gilbeau L, Kantor G, Stoeckle E et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother. Oncol.65(3), 137–143 (2002).
   PubMed Web of Science ®Google Scholar
• Pisters PW, O’Sullivan B. Retroperitoneal sarcomas: combined modality treatment approaches. Curr. Opin. Oncol.14(4), 400–405 (2002).
   PubMed Web of Science ®Google Scholar
• Gieschen HL, Spiro IJ, Suit HD et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int. J. Radiat. Oncol. Biol. Phys.50(1), 127–131 (2001).
   PubMed Web of Science ®Google Scholar
• Jones JJ, Catton CN, O’Sullivan B et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann. Surg. Oncol.9(4), 346–354 (2002).
   PubMed Web of Science ®Google Scholar
• Petersen IA, Haddock MG, Donohue JH et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys.52(2), 469–475 (2002).
   PubMed Web of Science ®Google Scholar
• Pisters PW, Ballo MT, Fenstermacher MJ et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J. Clin. Oncol.21(16), 3092–3097 (2003).
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Pisters PW, Mikula L et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann. Surg. Oncol.13(4), 508–517 (2006).
   PubMed Web of Science ®Google Scholar
• O’Sullivan B, Ward I, Haycocks T, Sharpe M. Techniques to modulate radiotherapy toxicity and outcome in soft tissue sarcoma. Curr. Treat. Options Oncol.4(6), 453–464 (2003).
   PubMedGoogle Scholar
• Bossi A, De Wever I, Van Limbergen E, Vanstraelen B. Intensity modulated radiation-therapy for preoperative posterior abdominal wall irradiation of retroperitoneal liposarcomas. Int. J. Radiat. Oncol. Biol. Phys.67(1), 164–170 (2007).
   PubMed Web of Science ®Google Scholar
• Koshy M, Landry JC, Lawson JD et al. Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction. Sarcoma7(3–4), 137–148 (2003).
   PubMedGoogle Scholar
• Tzeng CW, Fiveash JB, Popple RA et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer107(2), 371–379 (2006).
   PubMed Web of Science ®Google Scholar
• Musat E, Kantor G, Caron J et al. Comparison of intensity-modulated postoperative radiotherapy with conventional postoperative conformal radiotherapy for retroperitoneal sarcoma. Cancer Radiother.8(4), 255–261 (2004).
   PubMedGoogle Scholar
• Pezner RD, Liu A, Han C et al. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother. Oncol, 81(1), 81–87 (2006).
   PubMed Web of Science ®Google Scholar
• White JS, Biberdorf D, DiFrancesco LM, Kurien E, Temple W. Use of tissue expanders and pre-operative external beam radiotherapy in the treatment of retroperitoneal sarcoma. Ann. Surg. Oncol.14(2), 583–590 (2007).
   PubMed Web of Science ®Google Scholar
• Mikula LA, Ridgway PF, Catton CN et al. Long-term follow-up of a prospective trial of pre-operative external-beam radiation and post-operative brachytherapy for retroperitoneal sarcoma. Proceedings of the 14th Annual Meeting of the Connective Tissue Oncology Society London, UK, 13–15 November, 2008 (Abstract 35038).
   Google Scholar
• Yoon SS, Chen Y-L, Kirsch DG et al. Proton beam, intensity modulated, and/or intra-operative radiation therapy combined with aggressive anterior surgical resection for retroperitoneal and pelvic sarcomas. Proceedings of the 14th Annual Meeting of the Connective Tissue Oncology Society, London, UK, 13–15 November, 2008 (Abstract 34806).
   Google Scholar
• Fuser JL, Thomas JM, Hayes A, Ashley S, Saran F. Definitive radiotherapy for inoperable, intermediate and high grade retroperitoneal soft tissue sarcoma. Proceedings of the 14th Annual Meeting of the Connective Tissue Oncology Society London, UK, 13–15 November, 2008 (Abstract 34949).
   Google Scholar
• Warren-Oseni K, Lee YK, Hansen VN, Saran FH. Dose escalation in the treatment of retroperitoneal soft tissue sarcomas. Proceedings of the 14th Annual Meeting of the Connective Tissue Oncology Society, London, UK, 13–15 November, 2008 (Abstract 35027).
   Google Scholar
• Stoeckle E, Kantor G, Dejean C et al. Preoperative high-dose (54 Gy) helicoidal tomotherapy plus surgery in retroperitoneal liposarcoma: a feasibility study. Proceedings of the 14th Annual Meeting of the Connective Tissue Oncology Society London, UK, 13–15 November, 2008 (Abstract 35155).
   Google Scholar
• Goodman KA, Wolden SL, La Quaglia MP, Kushner BH. Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumor. Int. J. Radiat. Oncol. Biol. Phys.54(1), 170–176 (2002).
   PubMed Web of Science ®Google Scholar
• Aguilera D, Hayes-Jordan A, Anderson P et al. Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor. Sarcoma2008, 261589 (2008).
   PubMedGoogle Scholar
• Jahraus CD, Glisson SD, St Clair WH. Treatment of desmoplastic small round cell tumor with image-guided intensity modulated radiation therapy as a component of multimodality treatment. Tumori91(3), 253–255 (2005).
   PubMed Web of Science ®Google Scholar
• Oertel S, Niethammer AG, Krempien R et al. Combination of external-beam radiotherapy with intraoperative electron-beam therapy is effective in incompletely resected pediatric malignancies. Int. J. Radiat. Oncol. Biol. Phys.64(1), 235–241 (2006).
   PubMed Web of Science ®Google Scholar
• Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch. Surg.138(3), 248–251 (2003).
   PubMedGoogle Scholar
• Dalton RR, Donohue JH, Mucha P Jr. et al. Management of retroperitoneal sarcomas. Surgery106(4), 725–732 (1989).
   PubMed Web of Science ®Google Scholar
• Singer S, Corson JM, Demetri GD et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann. Surg.221(2), 185–195 (1995).
   PubMed Web of Science ®Google Scholar
• van Doorn RC, Gallee MP, Hart AA et al. Resectable retroperitoneal soft tissue sarcomas: the effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer73(3), 637–642 (1994).
   PubMed Web of Science ®Google Scholar
• Kilkenny JW 3rd, Bland KI, Copeland EM 3rd. Retroperitoneal sarcoma: the University of Florida experience. J. Am. Coll. Surg.182(4), 329–339 (1996).
   PubMed Web of Science ®Google Scholar
• Hassan I, Park SZ, Donohue JH et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann. Surg.239(2), 244–250 (2004).
   PubMed Web of Science ®Google Scholar
• van Dalen T, Plooij JM, van Coevorden F et al. Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur.J. Surg. Oncol.33(2), 234–238 (2007).
   PubMed Web of Science ®Google Scholar